Biotherapy. 1996;9(1-3):81-6.

Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports.

Ablashi DV, Levine PH, De Vinci C, Whitman JE Jr, Pizza G, Viza D.

Source

Advanced Biotechnologies Inc., Columbia, MD 21046, USA.

Abstract

Specific Human Herpes virus-6 (HHV-6) transfer factor (TF) preparation, administered to two chronic fatigue syndrome patients, inhibited the HHV-6 infection. Prior to treatment, both patients exhibited an activated HHV-6 infection. TF treatment significantly improved the clinical manifestations of CFS in one patient who resumed normal duties within weeks, whereas no clinical improvement was observed in the second patient. It is concluded that HHV-6 specific TF may be of significant value in controlling HHV-6 infection and related illnesses.

PMID:: 8993763; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Chronic Fatigue Syndrome - MedlinePlus Health Information

Supplemental Content

Related citations

Lessons from a pilot study of transfer factor in chronic fatigue syndrome. [Biotherapy. 1996]
Lessons from a pilot study of transfer factor in chronic fatigue syndrome.
De Vinci C, Levine PH, Pizza G, Fudenberg HH, Orens P, Pearson G, Viza D. Biotherapy. 1996; 9(1-3):87-90.
Review The use of transfer factors in chronic fatigue syndrome: prospects and problems. [Biotherapy. 1996]
Review The use of transfer factors in chronic fatigue syndrome: prospects and problems.
Levine PH. Biotherapy. 1996; 9(1-3):77-9.
Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. [J Infect Dis. 1995]
Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome.
Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB. J Infect Dis. 1995 Nov; 172(5):1364-7.
Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. [J Clin Virol. 2000]
Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.
Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR, Whitman JE. J Clin Virol. 2000 May; 16(3):179-91.
Review Is human herpesvirus-6 a trigger for chronic fatigue syndrome? [J Clin Virol. 2006]
Review Is human herpesvirus-6 a trigger for chronic fatigue syndrome?
Komaroff AL. J Clin Virol. 2006 Dec; 37 Suppl 1:S39-46.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Use of anti HHV-6 transfer factor for the treatment of two patients with chronic...
Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports.
Biotherapy. 1996 ;9(1-3):81-6.

PubMed
Does apolipoprotein E polymorphism influence susceptibility to malaria?
Does apolipoprotein E polymorphism influence susceptibility to malaria?
J Med Genet. 2003 May ;40(5):348-51.

PubMed
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk p...
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Diabetes Care. 2002 Nov ;25(11):1919-27.

PubMed
Protein kinase phosphorylation site sequences and consensus specificity motifs: ...
Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations.
Methods Enzymol. 1991 ;200:62-81.

PubMed
Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HC...
Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
Int J Cancer. 2010 May 15 ;126(10):2426-36.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information